Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-01-04 @ 12:35 PM
Study NCT ID:
NCT03836768
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2019-01-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma
Sponsor:
Zhejiang DTRM Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-30
First Submit QC Date:
None
Study First Post Date:
2019-02-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-14
Last Update Post Date:
2023-02-15
Last Update Post Date Type:
ACTUAL